Cite
Adkinson NF, Strauss WE, Bernard K, et al. Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions. J Blood Med. 2017;8:155-163doi: 10.2147/JBM.S142236.
Adkinson, N. F., Strauss, W. E., Bernard, K., Kaper, R. F., Macdougall, I. C., & Krop, J. S. (2017). Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions. Journal of blood medicine, 8155-163. https://doi.org/10.2147/JBM.S142236
Adkinson, N Franklin, et al. "Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions." Journal of blood medicine vol. 8 (2017): 155-163. doi: https://doi.org/10.2147/JBM.S142236
Adkinson NF, Strauss WE, Bernard K, Kaper RF, Macdougall IC, Krop JS. Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions. J Blood Med. 2017 Sep 26;8:155-163. doi: 10.2147/JBM.S142236. eCollection 2017. PMID: 29033620; PMCID: PMC5628663.
Copy
Download .nbib